Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: A pilot study

Pharmacological Research

Volumn 64, Issue 6, 2011, Pages 624-629

  Engebretson, Steven P ^a   Hey Hadavi, Judith ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

Antibiotic dose doxycycline; Chronic periodontitis; HbA1c; Periodontal therapy; Sub antimicrobial dose doxycycline; Type 2 diabetes

Indexed keywords

DOXYCYCLINE HYCLATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PLACEBO;

ADULT; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PILOT STUDY; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PERIODONTITIS; PILOT PROJECTS;

EID: 80054098536     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.06.024     Document Type: Article

References (39)

1. S.D. Luzio, D.R. Owens, J. Vora, J. Dolben, and H. Smith Intravenous insulin simulates early insulin peak and reduces post-prandial hyperglycaemia/hyperinsulinaemia in type 2 (non-insulin-dependent) diabetes mellitus Diabetes Res 16 1991 63 67
2. H.P. Hammes, X. Du, D. Edelstein, T. Taguchi, T. Matsumura, and Q. Ju Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy Nat Med 9 2003 294 299 (Pubitemid 36362784)
3. X.L. Du, D. Edelstein, L. Rossetti, I.G. Fantus, H. Goldberg, and F. Ziyadeh Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing sp1 glycosylation Proc Natl Acad Sci USA 97 2000 12222 12226
4. X.L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, and M. Brownlee Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the akt site J Clin Invest 108 2001 1341 1348 (Pubitemid 33107762)
5. X. Du, T. Matsumura, D. Edelstein, L. Rossetti, Z. Zsengeller, and C. Szabo Inhibition of gapdh activity by poly(adp-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells J Clin Invest 112 2003 1049 1057 (Pubitemid 38056320)
6. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 1315 1321
7. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor rage as a progression factor amplifying immune and inflammatory responses Diabetes 50 2001 2792 2808
8. M.M. Engelgau, T.J. Thompson, W.H. Herman, J.P. Boyle, R.E. Aubert, and S.J. Kenny Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited Diabetes Care 20 1997 785 791 (Pubitemid 27202529)
9. E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F.L. Brancati, and N.R. Powe Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann Intern Med 141 2004 421 431
10. J.F. Yale, T.R. Valiquett, M.N. Ghazzi, J.K. Owens-Grillo, R.W. Whitcomb, and H.L. Foyt The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial Ann Intern Med 134 2001 737 745 (Pubitemid 32402066)
11. D.G. Maggs, T.A. Buchanan, C.F. Burant, G. Cline, B. Gumbiner, and W.A. Hsueh Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial Ann Intern Med 128 1998 176 185 (Pubitemid 28078198)
12. S.E. Inzucchi Oral antihyperglycemic therapy for type 2 diabetes: scientific review JAMA 287 2002 360 372 (Pubitemid 34256388)
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
14. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403 (Pubitemid 34437694)
15. H. Loe Periodontal disease. The sixth complication of diabetes DiabetesCare 16 1993 329 334 (Pubitemid 23013872)
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 Suppl. 1 2003 S5 S20
17. K.T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk Ann Intern Med 141 2004 413 420
18. E.H. Wagner, N. Sandhu, K.M. Newton, D.K. McCulloch, S.D. Ramsey, and L.C. Grothaus Effect of improved glycemic control on health care costs and utilization JAMA 285 2001 182 189 (Pubitemid 32048520)
19. Executive summary: standards of medical care in diabetes - 2010 Diabetes Care 33 Suppl. 1 2010 S4 S10
20. K.C. Tan, W.S. Chow, S. Tam, R. Bucala, and J. Betteridge Association between acute-phase reactants and advanced glycation end products in type 2 diabetes Diabetes Care 27 2004 223 228 (Pubitemid 38196736)
21. R. Babaei-Jadidi, N. Karachalias, N. Ahmed, S. Battah, and P.J. Thornalley Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine Diabetes 52 2003 2110 2120 (Pubitemid 36919806)
22. A. Stitt, T.A. Gardiner, N.L. Alderson, P. Canning, N. Frizzell, and N. Duffy The age inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2002 2826 2832 (Pubitemid 34970937)
23. P.J. Thornalley Use of aminoguanidine (pimagedine) to prevent the formation of advanced glycation endproducts Arch Biochem Biophys 419 2003 31 40 (Pubitemid 37279141)
24. W.K. Bolton, D.C. Cattran, M.E. Williams, S.G. Adler, G.B. Appel, and K. Cartwright Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy Am J Nephrol 24 2004 32 40 (Pubitemid 38250484)
25. J.L. Wautier, C. Zoukourian, O. Chappey, M.P. Wautier, P.J. Guillausseau, and R. Cao Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats J Clin Invest 97 1996 238 243
26. A. Flyvbjerg, L. Denner, B.F. Schrijvers, R.G. Tilton, T.H. Mogensen, and S.R. Paludan Long-term renal effects of a neutralizing rage antibody in obese type 2 diabetic mice Diabetes 53 2004 166 172 (Pubitemid 38044711)
27. L.G. Bucciarelli, T. Wendt, W. Qu, Y. Lu, E. Lalla, and L.L. Rong Rage blockade stabilizes established atherosclerosis in diabetic apolipoprotein e-null mice Circulation 106 2002 2827 2835 (Pubitemid 35396983)
28. E. Lalla, I.B. Lamster, M. Feit, L. Huang, A. Spessot, and W. Qu Blockade of rage suppresses periodontitis-associated bone loss in diabetic mice J Clin Invest 105 2000 1117 1124 (Pubitemid 30217696)
29. M.E. Ryan, N.S. Ramamurthy, and L.M. Golub Tetracyclines inhibit protein glycation in experimental diabetes Adv Dent Res 12 1998 152 158
30. S.G. Grossi, F.B. Skrepcinski, T. DeCaro, D.C. Robertson, A.W. Ho, and R.G. Dunford Treatment of periodontal disease in diabetics reduces glycated hemoglobin J Periodontol 68 1997 713 719 (Pubitemid 27357899)
31. L.M. Golub, T. Sorsa, H.M. Lee, S. Ciancio, D. Sorbi, and N.S. Ramamurthy Doxycycline inhibits neutrophil (pmn)-type matrix metalloproteinases in human adult periodontitis gingiva Journal of Clinical Periodontology 22 1995 100 109
32. J.G. Caton, S.G. Ciancio, T.M. Blieden, M. Bradshaw, R.J. Crout, and A.F. Hefti Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis J Periodontol 71 2000 521 532 (Pubitemid 30602323)
33. M.J. Novak, L.P. Johns, R.C. Miller, and M.H. Bradshaw Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis J Periodontol 73 2002 762 769
34. C. Walker, J. Thomas, S. Nango, J. Lennon, J. Wetzel, and C. Powala Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis J Periodontol 71 2000 1465 1471
35. J. Thomas, C. Walker, and M. Bradshaw Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility J Periodontol 71 2000 1472 1483
36. American diabetes association: clinical practice recommendations 1997 Diabetes Care 20 Suppl. 1 1997 S1 S70
37. J.A. Jones, D.R. Miller, C.J. Wehler, S.E. Rich, E.A. Krall-Kaye, and L.C. McCoy Does periodontal care improve glycemic control? The department of veterans affairs dental diabetes study Journal of clinical periodontology 34 2007 46 52 (Pubitemid 44952518)
38. American diabetes association clinical practice recommendations 2001 Diabetes Care 24 Suppl. 1 2001 S1 S133
39. American diabetes association: clinical practice recommendations 2000 Diabetes Care 23 Suppl. 1 2000 S1 S116